Clinical Trial

Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids

Study acronym: ECCO
Enrolling by Invitation Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated March 26, 2025 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a single-arm, single-center, open-label, Phase II study aimed at assessing the efficacy of organoids in predicting the response to radiotherapy and chemotherapy in cervical cancer
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-16.
Trial Details
NCT Number NCT06786780
Lead Sponsor Chongqing University Cancer Hospital
Conditions Cervical Cancer Treated with Pelvic Radiotherapy, Cervical Cancers
Enrollment 50 participants
Start Date 2023-01-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-26